Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIndependent Health Step Therapy Prior Auth Policy …
    Ask Trek AI about this page
    CurrentIndependent HealthPolicy N/A

    Step Therapy Criteria

    Customize your policy alerts

    Sign up for all Independent Health policy alerts

    Know when Independent Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy requirements for drugs on the listed Independent Health/Pharmacy Benefit Dimensions formularies; affects prescribers and pharmacy prior authorization for members enrolled in the specified PDP Part D formulary.

    Policy Summary
    PayerIndependent Health
    PolicyStep Therapy Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionDocument prior authorization requires documentation of trial or failure of the specified first-line agent(s) before covering the requested product.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Multiplenumber of distinct step rules listed
    2026-05-01

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    document effective date
    2026 PDP Part D 5-tierformularies referenced

    Step Therapy Coverage Criteria

    Aliskiren Step Therapy

    Covered when ALL of the following are met

    Aliskiren 300 mg: Use of an angiotensin-II receptor blocker (ARB) first is required

    Aripiprazole Formulation Sequencing

    Covered when ALL of the following are met

    Aripiprazole formulations: Aripiprazole oral solution must be used before ODT; ODT must be used before oral films

    Sequencing across formulations

    EUCRISA Step Therapy

    Covered when ALL of the following are met

    EUCRISA: Prior use of either a topical corticosteroid OR a topical calcineurin inhibitor is required

    Either agent satisfies step

    Febuxostat Step Therapy

    Covered when ALL of the following are met

    Febuxostat 80 mg: Prior use of allopurinol is required

    SYMPAZAN Step Therapy

    Covered when ALL of the following are met

    SYMPAZAN films: Prior use of clobazam oral suspension is required

    TRELSTAR Step Therapy

    Covered when ALL of the following are met

    TRELSTAR injections: Prior use of Lupron Depot is required

    VERSACLOZ Step Therapy

    Covered when ALL of the following are met

    VERSACLOZ suspension: Prior use of clozapine ODT is required

    Doxercalciferol Step Therapy

    Covered when ALL of the following are met

    Doxercalciferol capsules: Prior use of calcitriol is required

    Required Prior Therapies (Sequencing)

    Coverage LabelStep requirement
    Aliskiren fumarate 300 mg
    Try an angiotensin-II receptor blocker (ARB) before aliskiren fumarate 300 mg
    Coverage LabelStep requirement
    Aripiprazole oral solution -> ODT -> oral films
    Aripiprazole oral solution must be used before aripiprazole ODT; aripiprazole ODT must be used before aripiprazole oral films
    Coverage LabelStep requirement
    EUCRISA (crisaborole) ointment
    Prior use of either a topical corticosteroid OR a topical calcineurin inhibitor is required before EUCRISA ointment
    Coverage LabelStep requirement
    Febuxostat 80 mg
    Try allopurinol before febuxostat 80 mg
    Coverage LabelStep requirement
    SYMPAZAN films
    Try clobazam oral suspension before SYMPAZAN films
    Coverage LabelStep requirement
    TRELSTAR injectable formulations
    Try Lupron Depot before TRELSTAR injectable formulations
    Coverage LabelStep requirement
    VERSACLOZ suspension
    Try clozapine ODT before VERSACLOZ suspension
    Coverage LabelStep requirement
    Doxercalciferol capsules
    Try calcitriol before doxercalciferol capsules

    Prior Authorization and Provider Guidance

    Prior Authorization

    Step therapy prior‑authorization requirement

    Prior authorization requires documentation of failure or trial of the specified first-line agent(s) listed for each product before covering the requested product.

    Step Therapy

    Try an ARB before aliskiren 300 mg

    Aliskiren fumarate 300 mg is subject to step therapy and requires prior use of an angiotensin‑II receptor blocker (ARB) before coverage.

    Step Therapy

    Aripiprazole formulation sequencing

    Sequencing across aripiprazole formulations is required: aripiprazole oral solution must be used before the orally‑disintegrating tablet (ODT), and the ODT must be used before aripiprazole oral films.

    Listed Products and Codes

    Listed products and indexNDC | plain
    aliskiren fumarate tablet 150 mg orallisted in index
    aliskiren fumarate tablet 300 mg orallisted in index / step rule
    aripiprazole tablet dispersible 10 mg oralODT listed
    aripiprazole tablet dispersible 15 mg oralODT listed
    doxercalciferol capsule 0.5 mcg orallisted in index
    doxercalciferol capsule 1 mcg orallisted in index
    doxercalciferol capsule 2.5 mcg orallisted in index
    EUCRISA OINTMENT 2 % EXTERNALlisted
    febuxostat tablet 40 mg orallisted
    febuxostat tablet 80 mg orallisted / step rule
    1–10 of 13
    1/2

    Policy Background

    This document lists the Step Therapy protocols used by the PDP Part D formulary to manage drug utilization and coverage. It is current as of May 1, 2026 and applies to the 2026 Pharmacy Benefit Dimensions Prescription Drug Plan (PDP) Part D 5‑Tier Formulary. The intent of these protocols is to require a trial and documented failure or intolerance of specified first‑line agent(s) before the formulary will cover alternative agents.

    Providers and pharmacies should follow the listed sequencing rules when submitting prior authorization requests; for questions about coverage or the formulary, contact Medicare Member Services at the phone numbers and hours shown in the formulary notice. The formulary may change and members will be notified of necessary updates.

    Policy Summary
    PayerIndependent Health
    PolicyStep Therapy Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionDocument prior authorization requires documentation of trial or failure of the specified first-line agent(s) before covering the requested product.
    SourceLink
    On This Page
    Step Therapy Coverage CriteriaRequired Prior Therapies (Sequencing)Prior Authorization and Provider GuidanceListed Products and CodesPolicy Background
    • Aripiprazole oral solution → Aripiprazole ODT
    • Aripiprazole ODT → Aripiprazole oral films
    Step Therapy

    Topical corticosteroid or calcineurin inhibitor required first

    EUCRISA (crisaborole) ointment requires prior use of either a topical corticosteroid or a topical calcineurin inhibitor before coverage.

    • Either a topical corticosteroid OR a topical calcineurin inhibitor satisfies the step
    Step Therapy

    Try allopurinol before febuxostat 80 mg

    Febuxostat 80 mg requires prior use of allopurinol before febuxostat will be covered.

    Step Therapy

    Clobazam oral suspension required before SYMPAZAN films

    SYMPAZAN films require prior use of clobazam oral suspension before coverage of the film formulation.

    Step Therapy

    Try Lupron Depot before TRELSTAR injections

    TRELSTAR injectable formulations require prior use of Lupron Depot before coverage of TRELSTAR injections.

    Step Therapy

    Clozapine ODT required before VERSACLOZ suspension

    VERSACLOZ oral suspension requires prior use of clozapine orally‑disintegrating tablet (ODT) before coverage.

    Step Therapy

    Try calcitriol before doxercalciferol capsules

    Doxercalciferol capsules require prior use of calcitriol before coverage will be provided.

    Denial Risk

    Denial risk if ARB not tried before aliskiren 300 mg

    Coverage may be denied if the required prior step (an angiotensin‑II receptor blocker) is not tried before aliskiren fumarate 300 mg.

    Denial Risk

    Enforce aripiprazole formulation sequence

    Aripiprazole oral solution must be tried before aripiprazole ODT, and aripiprazole ODT must be used before aripiprazole oral films; failure to follow sequencing may affect coverage.

    • Solution → ODT → Oral films
    Denial Risk

    EUCRISA requires prior topical steroid or calcineurin inhibitor

    Topical corticosteroid or topical calcineurin inhibitor must be used before EUCRISA (crisaborole) ointment; lack of prior use may lead to noncoverage.

    Denial Risk

    Denial risk if allopurinol not tried before febuxostat 80 mg

    Allopurinol must be tried before febuxostat 80 mg; coverage for febuxostat 80 mg is contingent on prior allopurinol use.

    Denial Risk

    SYMPAZAN requires prior clobazam suspension

    Clobazam oral suspension must be used before SYMPAZAN films; failure to try the suspension first may prevent coverage of the film.

    Denial Risk

    TRELSTAR coverage contingent on prior Lupron Depot

    Lupron Depot must be used before TRELSTAR injectable formulations; absence of prior Lupron Depot use may result in denial.

    Denial Risk

    VERSACLOZ requires prior clozapine ODT

    Clozapine ODT must be used before VERSACLOZ oral suspension; coverage depends on prior use of the ODT formulation.

    Denial Risk

    Doxercalciferol coverage requires prior calcitriol

    Calcitriol must be used before doxercalciferol capsules; lack of prior calcitriol therapy may lead to noncoverage.

    Note

    Member services and formulary notice

    For questions about formulary rules or coverage, contact Medicare Member Services at 1-800-667-5936 (TTY 711). The formulary may change and members will be notified.